KORU Medical Systems - KRMD Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $4.13
  • Forecasted Upside: 2.61%
  • Number of Analysts: 4
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 3 Buy Ratings
  • 1 Strong Buy Ratings
$4.02
▲ +0.32 (8.65%)

This chart shows the closing price for KRMD by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New KORU Medical Systems Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for KRMD and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for KRMD

Analyst Price Target is $4.13
▲ +2.61% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for KORU Medical Systems in the last 3 months. The average price target is $4.13, with a high forecast of $5.00 and a low forecast of $3.50. The average price target represents a 2.61% upside from the last price of $4.02.

This chart shows the closing price for KRMD for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Buy

The current consensus among 4 polled investment analysts is to buy stock in KORU Medical Systems. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/29/2023
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/27/2023
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/26/2023
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/25/2024
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/23/2024
  • 1 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/21/2024
  • 1 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/20/2024
  • 1 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/20/2024

Latest Recommendations

  • 1 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
11/14/2024Craig HallumBoost TargetBuy ➝ Buy$4.00 ➝ $5.00
11/14/2024Canaccord Genuity GroupBoost TargetBuy ➝ Buy$3.00 ➝ $4.00
11/14/2024Piper SandlerBoost TargetOverweight ➝ Overweight$3.00 ➝ $3.50
8/8/2024Piper SandlerBoost TargetOverweight ➝ Overweight$2.50 ➝ $3.00
7/25/2024B. RileyInitiated CoverageBuy$4.00
7/24/2024B. RileyUpgradeStrong-Buy
3/14/2024B. RileyReiterated RatingBuy ➝ Buy$4.00
12/12/2023B. RileyReiterated RatingBuy
12/7/2023Canaccord Genuity GroupReiterated RatingBuy ➝ Buy$3.00
9/7/2023Lake Street CapitalInitiated CoverageBuy$4.00
9/7/2023B. RileyInitiated CoverageBuy$4.50
8/3/2023Piper SandlerLower TargetOverweight ➝ Overweight$4.50 ➝ $3.00
1/6/2023Piper SandlerBoost TargetOverweight$3.50 ➝ $4.50
11/10/2022Canaccord Genuity GroupUpgradeHold ➝ Buy$3.00 ➝ $4.00
11/10/2022Piper SandlerUpgradeNeutral ➝ Overweight$3.00 ➝ $3.50
3/23/2021Piper SandlerLower TargetNeutral$4.50 ➝ $3.50
1/25/2021Piper SandlerDowngradeOverweight ➝ Neutral$9.00 ➝ $4.50
8/10/2020HC WainwrightInitiated CoverageBuy$16.00
8/5/2020Piper SandlerBoost TargetOverweight$12.00 ➝ $14.00
6/24/2020Piper SandlerInitiated CoverageOverweight$12.00
(Data available from 12/21/2019 forward)

News Sentiment Rating

0.28 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 2 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
5/25/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/24/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/24/2024
  • 4 very positive mentions
  • 10 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/23/2024
  • 2 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/22/2024
  • 2 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/22/2024
  • 1 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/21/2024
  • 1 very positive mentions
  • 1 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
12/21/2024

Current Sentiment

  • 1 very positive mentions
  • 1 positive mentions
  • 1 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.
KORU Medical Systems logo
KORU Medical Systems, Inc. develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The company was incorporated in 1980 and is based in Mahwah, New Jersey.
Read More

Today's Range

Now: $4.02
Low: $3.61
High: $4.03

50 Day Range

MA: $3.30
Low: $2.46
High: $4.40

52 Week Range

Now: $4.02
Low: $1.98
High: $4.60

Volume

209,200 shs

Average Volume

110,989 shs

Market Capitalization

$184.26 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.48

Frequently Asked Questions

What sell-side analysts currently cover shares of KORU Medical Systems?

The following Wall Street research analysts have issued reports on KORU Medical Systems in the last year: B. Riley, Canaccord Genuity Group Inc., Craig Hallum, and Piper Sandler.
View the latest analyst ratings for KRMD.

What is the current price target for KORU Medical Systems?

0 Wall Street analysts have set twelve-month price targets for KORU Medical Systems in the last year. Their average twelve-month price target is $4.13, suggesting a possible upside of 2.6%. Craig Hallum has the highest price target set, predicting KRMD will reach $5.00 in the next twelve months. Piper Sandler has the lowest price target set, forecasting a price of $3.50 for KORU Medical Systems in the next year.
View the latest price targets for KRMD.

What is the current consensus analyst rating for KORU Medical Systems?

KORU Medical Systems currently has 3 buy ratings and 1 strong buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe KRMD will outperform the market and that investors should add to their positions of KORU Medical Systems.
View the latest ratings for KRMD.

What other companies compete with KORU Medical Systems?

Other companies that are similar to KORU Medical Systems include Butterfly Network, Iradimed, AxoGen, Semler Scientific and SI-BONE. Learn More about companies similar to KORU Medical Systems.

How do I contact KORU Medical Systems' investor relations team?

KORU Medical Systems' physical mailing address is 24 CARPENTER RD, CHESTER NY, 10918. The company's listed phone number is (845) 469-2042 and its investor relations email address is [email protected]. The official website for KORU Medical Systems is www.korumedical.com. Learn More about contacing KORU Medical Systems investor relations.